YOLO ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
MSOS	F	3.27	35.08
HITI	B	-2.26	11.58
SNDL	F	0.00	7.02
REFI	A	0.77	4.06
JAZZ	A	-2.11	3.63
OGI	F	-4.00	3.38
AFCG	F	-1.41	3.33
TLRY	F	-2.17	2.28
INM	B	-15.73	0.62

Represented by ETF Holdings

Keywords: Cannabis Medicine Entheogens Euphoriants Medicinal Plants Health Sciences Herbalism Medical Cannabis Real Estate Investment Trust Drugs Loan Plants Psychoactive Drugs Acute Lymphoblastic Leukemia Antibiotics Asparaginase Biopharmaceutical Biotechnology Bone CBD

Industries: Drug Manufacturers - Specialty & Generic Biotechnology Pharmaceutical Retailers REIT - Mortgage REIT - Specialty

Recent News for AdvisorShares Pure Cannabis ETF & its Holdings

Date	Stock	Title
Nov 15	SNDL	Cannabis retailer SNDL announces renewal of share repurchase program
Nov 15	SNDL	SNDL Announces Renewal of Share Repurchase Program
Nov 15	TLRY	Tilray Joins German Cannabis Fiesta With First Locally Grown Strains
Nov 15	MSOS	Selling Weed Is Like A Sneaker Drop: Running Out Isn't A Problem For This Company
Nov 14	JAZZ	Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock?
Nov 14	TLRY	Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster Hall
Nov 14	MSOS	Cannabis stocks gain as Trump picks pro-marijuana Congressman Gaetz for AG post
Nov 14	TLRY	Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
Nov 14	JAZZ	Jazz Pharmaceuticals' (NASDAQ:JAZZ) Performance Is Even Better Than Its Earnings Suggest
Nov 13	MSOS	Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
Nov 13	JAZZ	Baupost's top Q3 trades include Jazz exit, new Dollar General stake
Nov 13	MSOS	Matt Gaetz Is Trump's Attorney General Pick: Would-Be Top Cop Is Under House Ethics Investigation
Nov 13	JAZZ	Jazz (JAZZ) Upgraded to Buy: Here's Why
Nov 13	JAZZ	Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High?
Nov 13	JAZZ	Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now?
Nov 13	TLRY	Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party
Nov 13	TLRY	Breckenridge Distillery's Latest Creation is the Perfect Addition to Your Holiday Bar: Breckenridge Candy Cane Vodka
Nov 13	HITI	High Tide Announces Closing of Final Tranche of $15 Million Subordinated Debt Facility
Nov 13	AFCG	Earnings Scheduled For November 13, 2024
Nov 13	MSOS	Did Cannabis Stocks Finally Bottom?

Cannabis and its various applications have been used throughout human civilization for over 5,000 years. As society, business and regulatory landscapes evolve in the 21st century, the upside potential of cannabis as an emerging investment avenue has arrived. The portfolio manager believes today’s new era can be viewed in similar regard to post-Prohibition, commencing a growing acknowledgement and understanding of cannabis and its uses among a mainstream audience. The industries that comprise the multi-billion dollar cannabis universe represent a new frontier, where proper caution and due diligence must be exercised surrounding its regulations and risks, in seeking attractive long-term cannabis investment opportunities. The AdvisorShares Pure Cannabis ETF (Ticker: YOLO) became the first actively managed ETF with a dedicated cannabis investment mandate domiciled in the United States. The AdvisorShares Pure Cannabis ETF, or YOLO, seeks long-term capital appreciation by investing in both domestic and foreign cannabis equity securities. YOLO is designed to fully-invest for pure cannabis exposure under the guidance of a deeply experienced portfolio management team navigating the emerging cannabis marketplace.
Exchange Traded Fund ETF Exchange Traded Funds Advisorshares Cannabis Portfolio Management Psychoactive Drugs Euphoriants Entheogens Medicinal Plants Cannabis Smoking Portfolio Manager

ETF Components for YOLO - AdvisorShares Pure Cannabis ETF